Takamasa Horio (asialaw)

Life Science / Healthcare

Crisis Management / Compliance

• Internal Investigations
• Global Compliance
• Whistleblowing

M&A

• M&A / Reorganizations / Capital and Business Alliances
• Cross-Border M&A
• Private Equity
• Start-Ups

Intellectual Property

• Intellectual Property Transactions
• Intellectual Property Disputes

Corporate Law

• Corporate Governance

• Represented Santen Pharmaceutical in connection with its sale of anti-rheumatic business to Showa Yakuhin Kako
  

• Doshisha University (LL.B., 2006)
• Kyoto University Law School (J.D., 2008)
• Northwestern University School of Law (LL.M. with honors, 2016)
• Northwestern University School of Law, Kellogg School of Management (Certificate in Business Administration, 2016)
• Jenner & Block LLP, Chicago (2016-2017)
• seconded to the Pharmaceutical Bureau (Compliance and Narcotics Division, Pharmaceutical Evaluation Division, and Medical Device Evaluation Division) of the Ministry of Health, Labour and Welfare (as Legal Adviser) (2017-2020)